医学
急性肾损伤
心力衰竭
心肾综合症
内科学
丝氨酸蛋白酶
肾
细胞因子
心脏病学
心室重构
蛋白酵素
促炎细胞因子
下调和上调
颗粒酶B
细胞外基质
心脏功能不全
内分泌学
心脏病
丝氨酸
纤维化
肾脏疾病
蛋白酶
心脏纤维化
免疫系统
作者
Pramod S. Gowda,Stanley Qu,Nadezhda N. Zheleznova,M.X. Li,Nohely Hernandez Soto,Lei Wang,Nathan Hall,Runze Ni,Bi Zhao,Justin Gibbons,Quamarul Hassan,Nilam Sanjib Banerjee,Ganesh V. Halade,Lucian Lozonschi,Enyin Lai,Kristof Williams,Ruisheng Liu
标识
DOI:10.1161/jaha.125.046513
摘要
Background Cardiorenal syndrome type 3 describes cardiac injury triggered by acute kidney injury (AKI). AKI caused by ischemia reperfusion injury represents a model for kidney injury during kidney transplant. It is well known that kidney transplant recipients are at increased risk to develop cardiac fibrosis; however, the molecular mechanisms linking renal injury to myocardial remodeling or cardiac fibrosis remain unclear. Methods Using a C57BL/6J mouse model of ischemia reperfusion injury–AKI, we combined proteomics and RNA seqencing transcriptomics to define early cardiac responses. We validated the proteomics and RNA sequencing data with quantitative polymerase chain reaction, ELISA, cytokine array, and western blotting for profibrotic and injury markers. We assessed SerpinA3N function using a granzyme B activity assay kit and XAV939, an inhibitor of SerpinA3N. Ingenuity pathway analysis further confirmed serine protease activity inhibition and increased expression of cardiac fibrosis–related genes after AKI. Results Successful establishment of renal ischemia reperfusion injury causing AKI, followed by significant induction of cardiac injury. AKI significantly upregulated SerpinA3N in the heart while suppressing serine protease (granzyme B) activity. Concomitantly, AKI hearts displayed elevated profibrotic genes ( FN1, COL1A1, TGF‐β1 ), mitochondrial dysfunction, and heightened inflammatory signaling. In vitro, inhibition of SerpinA3N with XAV939 restored granzyme B activity, confirming direct suppression by SerpinA3N. Conclusions We conclude that SerpinA3N serves as a key mediator of cardiorenal syndrome type 3 pathogenesis, by inhibiting granzyme B, which promotes profibrotic remodeling in the heart following AKI. Targeting SerpinA3N could be a potential therapeutic approach that restores balanced extracellular matrix turnover and mitigates cardiac fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI